Concepts (169)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Pancreatic Neoplasms | 6 | 2022 | 4930 | 0.760 |
Why?
|
| Adenocarcinoma | 7 | 2022 | 6338 | 0.720 |
Why?
|
| Cholangiopancreatography, Magnetic Resonance | 2 | 2016 | 94 | 0.700 |
Why?
|
| Gastroenterology | 2 | 2021 | 518 | 0.690 |
Why?
|
| Hospitalists | 1 | 2021 | 292 | 0.630 |
Why?
|
| Carcinoma, Pancreatic Ductal | 3 | 2022 | 1481 | 0.540 |
Why?
|
| Cholangiopancreatography, Endoscopic Retrograde | 1 | 2015 | 487 | 0.470 |
Why?
|
| Carcinoma in Situ | 2 | 2016 | 821 | 0.400 |
Why?
|
| Early Detection of Cancer | 4 | 2022 | 2865 | 0.390 |
Why?
|
| Cecum | 1 | 2010 | 235 | 0.390 |
Why?
|
| Pancreas | 2 | 2015 | 1688 | 0.350 |
Why?
|
| Esophagogastric Junction | 1 | 2010 | 297 | 0.350 |
Why?
|
| Foreign-Body Migration | 1 | 2010 | 227 | 0.340 |
Why?
|
| Stomach Neoplasms | 2 | 2015 | 1214 | 0.280 |
Why?
|
| Barrett Esophagus | 2 | 2021 | 497 | 0.270 |
Why?
|
| Carcinoma | 1 | 2016 | 2307 | 0.260 |
Why?
|
| Telomere | 2 | 2020 | 823 | 0.250 |
Why?
|
| CA-19-9 Antigen | 1 | 2020 | 102 | 0.200 |
Why?
|
| Gallbladder Diseases | 1 | 2021 | 124 | 0.200 |
Why?
|
| Ambulatory Care | 3 | 2021 | 2765 | 0.200 |
Why?
|
| Endosonography | 3 | 2021 | 573 | 0.180 |
Why?
|
| Positron-Emission Tomography | 1 | 2015 | 6170 | 0.180 |
Why?
|
| Telangiectasis | 1 | 2018 | 76 | 0.170 |
Why?
|
| Colonoscopy | 4 | 2022 | 1335 | 0.170 |
Why?
|
| Stents | 1 | 2010 | 3312 | 0.170 |
Why?
|
| Pancreatitis, Chronic | 2 | 2020 | 269 | 0.160 |
Why?
|
| Chromatin Assembly and Disassembly | 1 | 2021 | 621 | 0.150 |
Why?
|
| Gastric Fistula | 1 | 2017 | 73 | 0.150 |
Why?
|
| Peutz-Jeghers Syndrome | 1 | 2016 | 47 | 0.150 |
Why?
|
| Intestinal Fistula | 1 | 2017 | 150 | 0.150 |
Why?
|
| Delayed Diagnosis | 1 | 2019 | 409 | 0.140 |
Why?
|
| Neoplasm Staging | 3 | 2022 | 11126 | 0.140 |
Why?
|
| Arteriovenous Fistula | 1 | 2018 | 300 | 0.140 |
Why?
|
| Colorectal Neoplasms | 3 | 2022 | 6497 | 0.140 |
Why?
|
| Gastrointestinal Tract | 1 | 2021 | 834 | 0.130 |
Why?
|
| Medication Errors | 1 | 2021 | 772 | 0.130 |
Why?
|
| Pancreatic Ducts | 1 | 2015 | 330 | 0.120 |
Why?
|
| Gastrointestinal Hemorrhage | 1 | 2020 | 1055 | 0.120 |
Why?
|
| Natural Language Processing | 1 | 2021 | 936 | 0.120 |
Why?
|
| Tomography, X-Ray Computed | 3 | 2015 | 20308 | 0.120 |
Why?
|
| Pulmonary Veins | 1 | 2018 | 709 | 0.120 |
Why?
|
| Gastrointestinal Diseases | 1 | 2021 | 1148 | 0.120 |
Why?
|
| Hypnotics and Sedatives | 1 | 2021 | 1108 | 0.120 |
Why?
|
| Colorectal Neoplasms, Hereditary Nonpolyposis | 1 | 2016 | 371 | 0.110 |
Why?
|
| Precancerous Conditions | 1 | 2018 | 964 | 0.110 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2010 | 8877 | 0.110 |
Why?
|
| Decision Support Systems, Clinical | 1 | 2021 | 1155 | 0.110 |
Why?
|
| Elasticity Imaging Techniques | 1 | 2015 | 366 | 0.100 |
Why?
|
| Endoscopy | 1 | 2021 | 1754 | 0.100 |
Why?
|
| Biopsy, Fine-Needle | 1 | 2015 | 1066 | 0.100 |
Why?
|
| Laparoscopy | 1 | 2021 | 1981 | 0.100 |
Why?
|
| Mixed Tumor, Malignant | 1 | 2009 | 16 | 0.090 |
Why?
|
| Pulmonary Artery | 1 | 2018 | 1899 | 0.090 |
Why?
|
| Gastric Bypass | 1 | 2017 | 727 | 0.090 |
Why?
|
| Academic Medical Centers | 1 | 2019 | 2779 | 0.090 |
Why?
|
| Mass Screening | 2 | 2022 | 5182 | 0.090 |
Why?
|
| Stem Cells | 1 | 2021 | 3593 | 0.080 |
Why?
|
| Obesity, Morbid | 1 | 2017 | 1066 | 0.080 |
Why?
|
| Esophageal Neoplasms | 1 | 2016 | 1449 | 0.080 |
Why?
|
| Humans | 22 | 2022 | 708843 | 0.070 |
Why?
|
| Quality Improvement | 1 | 2022 | 3733 | 0.070 |
Why?
|
| Healthcare Disparities | 1 | 2021 | 2996 | 0.070 |
Why?
|
| Guideline Adherence | 1 | 2016 | 2315 | 0.070 |
Why?
|
| Telemedicine | 1 | 2021 | 2583 | 0.070 |
Why?
|
| Neoplasm Metastasis | 1 | 2015 | 5112 | 0.060 |
Why?
|
| Health Services Accessibility | 1 | 2021 | 4988 | 0.060 |
Why?
|
| Registries | 1 | 2019 | 7989 | 0.060 |
Why?
|
| Risk | 1 | 2016 | 9641 | 0.060 |
Why?
|
| Genetic Variation | 1 | 2018 | 6666 | 0.060 |
Why?
|
| Genomics | 1 | 2018 | 5300 | 0.060 |
Why?
|
| Gene Expression Profiling | 1 | 2018 | 9556 | 0.050 |
Why?
|
| Metaplasia | 1 | 2021 | 314 | 0.050 |
Why?
|
| Central Nervous System Cysts | 1 | 2020 | 58 | 0.050 |
Why?
|
| Dyskeratosis Congenita | 1 | 2020 | 74 | 0.050 |
Why?
|
| Gallbladder | 1 | 2021 | 307 | 0.050 |
Why?
|
| Muscle Spasticity | 1 | 2020 | 143 | 0.050 |
Why?
|
| Deep Sedation | 1 | 2021 | 113 | 0.050 |
Why?
|
| Radiography | 1 | 2010 | 6989 | 0.050 |
Why?
|
| Videoconferencing | 1 | 2021 | 190 | 0.040 |
Why?
|
| Ataxia | 1 | 2020 | 281 | 0.040 |
Why?
|
| Adult | 9 | 2021 | 211041 | 0.040 |
Why?
|
| Telephone | 1 | 2021 | 624 | 0.040 |
Why?
|
| Leukoencephalopathies | 1 | 2020 | 252 | 0.040 |
Why?
|
| Pancreatic Cyst | 1 | 2020 | 346 | 0.040 |
Why?
|
| Anastomosis, Roux-en-Y | 1 | 2017 | 78 | 0.040 |
Why?
|
| Bone Diseases, Metabolic | 1 | 2020 | 398 | 0.040 |
Why?
|
| Jejunal Diseases | 1 | 2017 | 49 | 0.040 |
Why?
|
| Fetal Growth Retardation | 1 | 2020 | 545 | 0.040 |
Why?
|
| Microcephaly | 1 | 2020 | 392 | 0.040 |
Why?
|
| Thorax | 1 | 2019 | 512 | 0.040 |
Why?
|
| Office Visits | 1 | 2021 | 629 | 0.040 |
Why?
|
| Conscious Sedation | 1 | 2021 | 505 | 0.040 |
Why?
|
| Aged | 8 | 2021 | 161488 | 0.040 |
Why?
|
| Epigenomics | 1 | 2021 | 802 | 0.040 |
Why?
|
| Ulcer | 1 | 2017 | 186 | 0.040 |
Why?
|
| Drainage | 1 | 2021 | 1131 | 0.040 |
Why?
|
| Female | 11 | 2021 | 375205 | 0.040 |
Why?
|
| Male | 11 | 2022 | 349524 | 0.030 |
Why?
|
| Ambulatory Care Facilities | 1 | 2022 | 883 | 0.030 |
Why?
|
| Education | 1 | 2018 | 540 | 0.030 |
Why?
|
| Middle Aged | 9 | 2021 | 213752 | 0.030 |
Why?
|
| Workflow | 1 | 2019 | 803 | 0.030 |
Why?
|
| Retinal Diseases | 1 | 2020 | 673 | 0.030 |
Why?
|
| Enhancer Elements, Genetic | 1 | 2021 | 1378 | 0.030 |
Why?
|
| Prostate | 1 | 2022 | 1564 | 0.030 |
Why?
|
| Endoscopy, Digestive System | 1 | 2017 | 336 | 0.030 |
Why?
|
| Esophagoscopy | 1 | 2016 | 401 | 0.030 |
Why?
|
| Early Diagnosis | 1 | 2019 | 1192 | 0.030 |
Why?
|
| Neoplasms | 1 | 2022 | 20172 | 0.030 |
Why?
|
| Colectomy | 1 | 2018 | 651 | 0.030 |
Why?
|
| Mucous Membrane | 1 | 2016 | 677 | 0.030 |
Why?
|
| Immunohistochemistry | 2 | 2021 | 11790 | 0.030 |
Why?
|
| Calcinosis | 1 | 2020 | 1435 | 0.030 |
Why?
|
| DNA Mutational Analysis | 1 | 2021 | 4317 | 0.030 |
Why?
|
| Hyperlipidemias | 1 | 2017 | 796 | 0.030 |
Why?
|
| Cell Lineage | 1 | 2021 | 2630 | 0.030 |
Why?
|
| Aged, 80 and over | 4 | 2018 | 58184 | 0.030 |
Why?
|
| Feasibility Studies | 1 | 2020 | 4883 | 0.030 |
Why?
|
| Gastrectomy | 1 | 2015 | 538 | 0.030 |
Why?
|
| MAP Kinase Signaling System | 1 | 2018 | 1588 | 0.020 |
Why?
|
| Single-Cell Analysis | 1 | 2021 | 2159 | 0.020 |
Why?
|
| Program Evaluation | 1 | 2019 | 2524 | 0.020 |
Why?
|
| Germ-Line Mutation | 1 | 2018 | 1730 | 0.020 |
Why?
|
| Bone Marrow | 1 | 2020 | 2938 | 0.020 |
Why?
|
| Carcinoma, Islet Cell | 1 | 2009 | 23 | 0.020 |
Why?
|
| Sequence Analysis, RNA | 1 | 2018 | 2040 | 0.020 |
Why?
|
| Diarrhea | 1 | 2017 | 1354 | 0.020 |
Why?
|
| Mucin-2 | 1 | 2009 | 50 | 0.020 |
Why?
|
| Gene Regulatory Networks | 1 | 2018 | 1712 | 0.020 |
Why?
|
| Synaptophysin | 1 | 2009 | 142 | 0.020 |
Why?
|
| Retina | 1 | 2020 | 2649 | 0.020 |
Why?
|
| Odds Ratio | 1 | 2022 | 9754 | 0.020 |
Why?
|
| DNA Repair | 1 | 2018 | 2028 | 0.020 |
Why?
|
| Seizures | 1 | 2020 | 2562 | 0.020 |
Why?
|
| Massachusetts | 1 | 2021 | 8712 | 0.020 |
Why?
|
| Risk Factors | 3 | 2021 | 69553 | 0.020 |
Why?
|
| Colonic Neoplasms | 1 | 2019 | 2535 | 0.020 |
Why?
|
| Socioeconomic Factors | 1 | 2021 | 7644 | 0.020 |
Why?
|
| Mutation | 2 | 2021 | 29262 | 0.020 |
Why?
|
| Retrospective Studies | 3 | 2021 | 71483 | 0.020 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2018 | 3708 | 0.020 |
Why?
|
| Preoperative Care | 1 | 2015 | 2357 | 0.020 |
Why?
|
| Adenocarcinoma, Mucinous | 1 | 2009 | 485 | 0.020 |
Why?
|
| Sensitivity and Specificity | 1 | 2020 | 14836 | 0.020 |
Why?
|
| Diagnosis, Differential | 1 | 2020 | 13274 | 0.020 |
Why?
|
| Incidence | 1 | 2022 | 20320 | 0.020 |
Why?
|
| Cohort Studies | 2 | 2016 | 39292 | 0.020 |
Why?
|
| Phenotype | 1 | 2021 | 16306 | 0.020 |
Why?
|
| Carcinoma, Papillary | 1 | 2009 | 798 | 0.020 |
Why?
|
| Catheter Ablation | 1 | 2016 | 2506 | 0.020 |
Why?
|
| Young Adult | 2 | 2020 | 55940 | 0.010 |
Why?
|
| Predictive Value of Tests | 1 | 2018 | 15252 | 0.010 |
Why?
|
| Disease Progression | 1 | 2018 | 13298 | 0.010 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2018 | 8638 | 0.010 |
Why?
|
| Adolescent | 2 | 2020 | 84718 | 0.010 |
Why?
|
| Proportional Hazards Models | 1 | 2016 | 12292 | 0.010 |
Why?
|
| Risk Assessment | 1 | 2021 | 23284 | 0.010 |
Why?
|
| Brain Neoplasms | 1 | 2020 | 8776 | 0.010 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2021 | 17218 | 0.010 |
Why?
|
| Body Mass Index | 1 | 2017 | 12366 | 0.010 |
Why?
|
| Child, Preschool | 1 | 2020 | 41081 | 0.010 |
Why?
|
| Time Factors | 1 | 2018 | 41038 | 0.010 |
Why?
|
| Ultrasonography | 1 | 2009 | 5918 | 0.010 |
Why?
|
| Lung Neoplasms | 1 | 2019 | 12183 | 0.010 |
Why?
|
| Postoperative Complications | 1 | 2017 | 15053 | 0.010 |
Why?
|
| United States | 1 | 2020 | 67165 | 0.010 |
Why?
|
| Child | 1 | 2020 | 73636 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2016 | 61932 | 0.010 |
Why?
|
| Animals | 1 | 2018 | 170486 | 0.000 |
Why?
|
Concepts
(169)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(72)
People in Profiles who have published with this person.
Explore
_
Similar People
(59)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_